Fresolimumab
Fresolimumab | |
---|---|
Term | Fresolimumab |
Short definition | freeze-dried (Freez-Dride) A method of drying substances such as food to give them a longer shelf life. The substance is frozen and then dried in vacuo |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Fresolimumab - (pronounced) (FREH-soh-LIM-yoo-mab) A substance being studied to treat breast cancer that has spread to other parts of the body. It is also being studied in the treatment of other cancers and diseases. Fresolimumab attaches to a protein called transforming growth factor-beta (TGF-beta) found on some cancer cells. Fresolimumab can help stop cancer cells from growing and stop the growth of new blood vessels that tumors need to grow. It's a type of monoclonal antibody and a type of anti-angiogenesis drug. Also referred to as anti-TGF-beta monoclonal antibody GC1008 and GC1008
External links
- Medical encyclopedia article on Fresolimumab
- Wikipedia's article - Fresolimumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski